All Stories

  1. Selenoureido-N-alkyl-3,4,5-trihydroxypiperidines: probing their dual-target role in Gaucher disease
  2. Simultaneous Grafting of 3,4,5‐Trihydroxypiperidine Iminosugars Onto Multivalent Scaffolds via Double Reductive Amination Provides New GCase Inhibitors
  3. An Ongoing Search for Multitarget Ligands as Potential Agents for Diabetes Mellitus and Its Long-Term Complications: New Insights into (5-Arylidene-4-oxothiazolidin-3-yl)alkanoic Acid Derivatives
  4. Acetal functionalized iminosugars for targeting β-glucocerebrosidase modulation
  5. Molecular Basis of Pseudomonas syringae pv actinidiae Levansucrase Inhibition by a Multivalent Iminosugar
  6. Rational design and synthesis of novel N-benzylindole-based epalrestat analogs as selective aldose reductase inhibitors: An unexpected discovery of a new glucose-lowering agent (AK-4) acting as a mitochondrial uncoupler
  7. Iminosugar‐Dihydroazulenes as Mutant L444P Glucocerebrosidase Enhancers
  8. Effect of Bovine Milk Peptides on Cell Inflammation, Proliferation and Differentiation: Milk Potential Benefits Are Preserved in an Unconventional Cow Feeding Strategy
  9. Rumen microbial community and milk quality in Holstein lactating cows fed olive oil pomace as part in a sustainable feeding strategy
  10. Light‐Triggered Control of Glucocerebrosidase Inhibitors: Towards Photoswitchable Pharmacological Chaperones
  11. Evidence of Insulin-Sensitizing and Mimetic Activity of the Sesquiterpene Quinone Avarone, a Protein Tyrosine Phosphatase 1B and Aldose Reductase Dual Targeting Agent from the Marine Sponge Dysidea avara
  12. Gold nanoparticles decorated with monosaccharides and sulfated ligands as potential modulators of the lysosomal enzyme N-acetylgalactosamine-6-sulfatase (GALNS)
  13. Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis
  14. 3,4,5‐Trihydroxypiperidine Based Multivalent Glucocerebrosidase (GCase) Enhancers
  15. Identifying Human PTP1B Enzyme Inhibitors from Marine Natural Products: Perspectives for Developing of Novel Insulin-Mimetic Drugs
  16. Insights into Cytotoxic Behavior of Lepadins and Structure Elucidation of the New Alkaloid Lepadin L from the Mediterranean Ascidian Clavelina lepadiformis
  17. Photoswitchable inhibitors of human β-glucocerebrosidase
  18. Dual Targeting of PTP1B and Aldose Reductase with Marine Drug Phosphoeleganin: A Promising Strategy for Treatment of Type 2 Diabetes
  19. Natural α-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitors: A Source of Scaffold Molecules for Synthesis of New Multitarget Antidiabetic Drugs
  20. Bioactive Properties of Breads Made with Sourdough of Hull-Less Barley or Conventional and Pigmented Wheat Flours
  21. Enzymatic Inhibitors from Natural Sources: A Huge Collection of New Potential Drugs
  22. In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications—A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B
  23. Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment
  24. Antioxidant and anti-inflammatory properties of sourdoughs containing selected Lactobacilli strains are retained in breads
  25. Does Fermentation Really Increase the Phenolic Content in Cereals? A Study on Millet
  26. miR‐210‐3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5‐fluorouracil
  27. Dual targeting of PTP1B and glucosidases with new bifunctional iminosugar inhibitors to address type 2 diabetes
  28. Honey extracts inhibit PTP1B, upregulate insulin receptor expression, and enhance glucose uptake in human HepG2 cells
  29. Development of Light-Responsive Liquid Crystalline Elastomers to Assist Cardiac Contraction
  30. Study on a Fermented Whole Wheat: Phenolic Content, Activity on PTP1B Enzyme and In Vitro Prebiotic Properties
  31. LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy
  32. Stereoselective Synthesis of C-2 Alkylated Trihydroxypiperidines: Novel Pharmacological Chaperones for Gaucher Disease
  33. Morin-dependent inhibition of low molecular weight protein tyrosine phosphatase (LMW-PTP) restores sensitivity to apoptosis during colon carcinogenesis: Studies in vitro and in vivo, in an Apc -driven model of colon cancer
  34. Liquid Crystal-Induced Myoblast Alignment
  35. In depth study of phenolic profile and PTP-1B inhibitory power of cold-pressed grape seed oils of different varieties
  36. Multiwalled carbon nanotubes for combination therapy: a biodistribution and efficacy pilot study
  37. Regulation of glucose metabolism by bioactive phytochemicals for the management of type 2 diabetes mellitus
  38. Design, synthesis, in vitro, in vivo and in silico pharmacological characterization of antidiabetic N-Boc-l-tyrosine-based compounds
  39. An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications
  40. Effect of selected strains of lactobacilli on the antioxidant and anti-inflammatory properties of sourdough
  41. LMW-PTP modulates glucose metabolism in cancer cells
  42. Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking study
  43. Metformin salts with oxidized multiwalled carbon nanotubes: In vitro biological activity and inhibition of CNT internalization
  44. Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy
  45. Ursolic acid derivatives as potential antidiabetic agents: In vitro , in vivo , and in silico studies
  46. Combined therapies with nanostructured carbon materials: there is room still available at the bottom
  47. Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair
  48. A single amino acid mutation affects elicitor and expansins-like activities of cerato-platanin, a non-catalytic fungal protein
  49. 4-Thiaflavanes as Inhibitors of Amyloid Aggregation
  50. Multiwalled carbon nanotubes for drug delivery: Efficiency related to length and incubation time
  51. Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents
  52. Low molecular weight protein tyrosine phosphatase: Multifaceted functions of an evolutionarily conserved enzyme
  53. In vitro and in silico PTP-1B inhibition and in vivo antidiabetic activity of semisynthetic moronic acid derivatives
  54. Morin: A Promising Natural Drug
  55. The “click-on-tube” approach for the production of efficient drug carriers based on oxidized multi-walled carbon nanotubes
  56. Evidence for a multivalent effect in inhibition of sulfatases involved in lysosomal storage disorders (LSDs)
  57. Cancer associated fibroblasts transfer lipids and proteins to cancer cells through cargo vesicles supporting tumor growth
  58. 5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits
  59. Azido-Substituted BODIPY Dyes for the Production of Fluorescent Carbon Nanotubes
  60. Human Acid β-Glucosidase Inhibition by Carbohydrate Derived Iminosugars: Towards New Pharmacological Chaperones for Gaucher Disease
  61. Effect of Natural Compounds on Insulin Signaling
  62. Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition
  63. Tumor Microenvironment and Metabolism in Prostate Cancer
  64. Synthesis, biological activity and structure–activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells
  65. Anoikis molecular pathways and its role in cancer progression
  66. The insulin-mimetic effect of Morin: A promising molecule in diabetes treatment
  67. Effect of IR laser on myoblasts: a proteomic study
  68. The effects of CA IX catalysis products within tumor microenvironment
  69. Synthesis, in vitro and in silico screening of ethyl 2-(6-substituted benzo[d]thiazol-2-ylamino)-2-oxoacetates as protein-tyrosine phosphatase 1B inhibitors
  70. New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells
  71. Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP–1B: In vitro, in silico, and in vivo approaches
  72. Protein N-Homocysteinylation Induces the Formation of Toxic Amyloid-Like Protofibrils
  73. PrPcactivation induces neurite outgrowth and differentiation in PC12 cells: role for caveolin-1 in the signal transduction pathway
  74. Structure-Based Optimization of Benzoic Acids as Inhibitors of Protein Tyrosine Phosphatase 1B and Low Molecular Weight Protein Tyrosine Phosphatase
  75. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity
  76. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors
  77. 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors
  78. Protective effect of new S-acylglutathione derivatives against amyloid-induced oxidative stress
  79. 5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases
  80. Low Molecular Weight Protein Tyrosine Phosphatase and Caveolin-1:  Interaction and Isoenzyme-Dependent Regulation†
  81. Site-directed mutagenesis of two aromatic residues lining the active site pocket of the yeast Ltp1
  82. Insulin Inhibits Platelet-derived Growth Factor-induced Cell Proliferation
  83. The in vivo tyrosine phosphorylation level of yeast immunophilin Fpr3 is influenced by the LMW-PTP Ltp1
  84. A Nucleophilic Catalysis Step is Involved in the Hydrolysis of Aryl Phosphate Monoesters by Human CT Acylphosphatase
  85. Hydrogen Peroxide Triggers the Formation of a Disulfide Dimer of Muscle Acylphosphatase and Modifies Some Functional Properties of the Enzyme
  86. Acylphosphatase possesses nucleoside triphosphatase and nucleoside diphosphatase activities
  87. Acylphosphatase Is a Strong Apoptosis Inducer in HeLa Cell Line
  88. The Contribution of Acidic Residues to the Conformational Stability of Common-Type Acylphosphatase
  89. Thermodynamics and Kinetics of Folding of Common-Type Acylphosphatase:  Comparison to the Highly Homologous Muscle Isoenzyme†
  90. Cloning of murine low molecular weight phosphotyrosine protein phosphatase cDNA: identification of a new isoform
  91. Mechanism of acylphosphatase inactivation by Woodward's reagent K
  92. Common-type acylphosphatase: steady-state kinetics and leaving-group dependence
  93. 2-Methoxybenzoyl phosphate: a new substrate for continuous fluorimetric and spectrophotometric acyl phosphatase assays
  94. Porcine liver low Mr phosphotyrosine protein phosphatase: The amino acid sequence